Clinical data | |
---|---|
Trade names | Xynor |
AHFS/ Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Via liver [1]: 1356 |
Elimination half-life | 12-13 hours [1]: 1356 |
Excretion | Urine (63%) and Feces (22%) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.037.099 |
Chemical and physical data | |
Formula | C7H10ClN3O3 |
Molar mass | 219.63 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Ornidazole is an antibiotic used to treat protozoan infections. [1]: 1368 A synthetic nitroimidazole, it is commercially obtained from an acid-catalyzed reaction between 2-methyl-5-nitroimidazole and epichlorohydrin. [2]
Antimicrobial spectrum is similar to that of metronidazole and is more well tolerated; [1]: 1368 however there are concerns of lower relative efficacy. [3]
It was first introduced for treating trichomoniasis before being recognized for its broad anti-protozoan and anti-anaerobic-bacterial capacities. [4]: 1261 has also been investigated for use in Crohn's disease after bowel resection. [5]